Please use this identifier to cite or link to this item:
https://ninho.inca.gov.br/jspui/handle/123456789/10244
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Amorim, Viviane Brandão | - |
dc.contributor.author | Parente, Daniella Braz | - |
dc.contributor.author | Paiva, Fernando Fernandes | - |
dc.contributor.author | Oliveira Neto, Jaime Araújo | - |
dc.contributor.author | Miranda, Amanda Almeida | - |
dc.contributor.author | Moreira, Cláudia Cravo | - |
dc.contributor.author | Fernandes, Flávia Ferreira | - |
dc.contributor.author | Campos, Carlos Frederico Ferreira | - |
dc.contributor.author | Leite, Nathalie Carvalho | - |
dc.contributor.author | Perez, Renata de Mello | - |
dc.contributor.author | Rodrigues, Rosana Souza | - |
dc.date.accessioned | 2022-08-19T12:42:30Z | - |
dc.date.available | 2022-08-19T12:42:30Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | AMORIM, Viviane Brandão et al. Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? World J Hepatol, v. 12, n. 9, p. 661-671, 2020. | - |
dc.identifier.issn | 1948-5182 | - |
dc.identifier.uri | http://sr-vmlxaph03:8080/jspui/handle/123456789/10244 | - |
dc.description | p. 661-671.: il. p&b. | - |
dc.description.abstract | Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. The diagnosis of nonalcoholic steatohepatitis (NASH), the most severe form of NAFLD, is crucial and has prognostic and therapeutic implications. However, currently this diagnosis is based on liver biopsy and has several limitations. | - |
dc.publisher | World J Hepatol | pt_BR |
dc.subject | Fígado Gorduroso | pt_BR |
dc.subject | Fatty Liver | pt_BR |
dc.subject | Hepatopatia Gordurosa não Alcoólica | pt_BR |
dc.subject | Non-alcoholic Fatty Liver Disease | pt_BR |
dc.subject | Gadolínio DTPA | pt_BR |
dc.subject | Gadolinium DTPA | pt_BR |
dc.title | Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? | pt_BR |
dc.Type | Article | pt_BR |
Appears in Collections: | Artigos de Periódicos da área de Radiologia |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver.pdf | 1.88 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.